PA/IVS has a low incidence but a high mortality rate, and great anatomical variation. Surgical programs are also diverse in each center, therefore, there is still no unified standard. Individualized surgical treatment is favourable, and the key step is to improve the early survival rate. According to our experience, few patients have one-stage radical operation; instead, most need staging surgery. For patients with mild and moderate right ventricular dysplasia and without RVDCC, right ventricular decompression should be performed as early as possible through initial surgery, thereby promoting the development of the right ventricle, improving the opportunity of biventricular repair in children[7,8], and eventually completing biventricular repair as early as possible[22].
Although much more surgical methods of right ventricular decompression are available for PA/IVS[9-14],surgical failure[15] and complications[16-19]are also universal. Hypoxemia is one of the most common complications for the following reasons: ( 1 ) Muscle edema of right ventricule, SpO2 in the early stage is not well maintained; ( 2 ) Hypoplastic right ventricle does not have sufficient pumping capacity to maintain the forward blood flow after the opening of pulmonary valve[20], and the pulmonary vascular bed pressure that has not been fully decreased in the neonatal period also limits the blood flow.
The measure to correct hypoxemia is to establish BT shunt. Nonetheless, it is still controversial whether decompression surgery is routinely combined with BT shunt.
Some studies have reported that BT shunt may lead to volume overload and left heart failure[6]. Our study believes that PDA is more likely to close when SpO2 becomes higher after right ventricular decompression, which has a great influence on the prognosis of PA/IVS. Therefore, PDA is routinely ligated and BT shunt surgery is added to ensure the stability and persistence of blood between systemic and pulmonary circulation.
In recent years, mosaic therapy has become a new approach for right ventricular decompression in the early stage of PA/IVS, which overcomes the shortcomings of interventional and surgical treatment, 23avoids the damage caused by cardiopulmonary bypass, with fast postoperative recovery, and could shorten the length of ICU stay.
Combined with mosaic therapy, surgical A has achieved good clinical results. Pulmonary valve incision without extracorporeal circulation is a simple procedure, which is free from extracorporeal circulation, with quick postoperative recovery.
Compared with surgical A, surgical B also have achieved good surgical results, and there were no differences in MVT, length of ICU stay, and perioperative mortality rate between group A and group B (P>0.05,Table 2). However, the mosaic therapy has several shortcomings, in which the puncture needle may be deviated from the center of the pulmonary valve, and the valve division is unevenly dilated, which finally reduces the function of the pulmonary valve. Due to tissue growth, adhesion, scar and other reasons after balloon dilatation, pulmonary valve will be reduced to varying degrees, hindering the growth of the right ventricle. The corresponding data showed that the PR was greater in group A than in group B at 1 and 3 months after surgery (P<0.05,Table 7).
The PTP was higher in group A than in group B at 3 months (P<0.05,Table 8), 6 months (P<0.01,Table 8), and 1 year after surgery (P<0.05,Table 8). Since pulmonary valve incision does not have the above-mentioned disadvantages, surgical B is better and more economical than surgical A, since it does not use intervention consumables.
Compared with surgical C, surgical D added an artificial pulmonary valve made of GORETEX membrane, which could reduce pulmonary valve regurgitation, protect right ventricular function, shorten MVT and length of ICU stay, promote right ventricular development, and improve the survival rate of initial surgery to a certain extent. The corresponding data showed that the PR was higher in group C than in group B at discharge (P<0.05,Table 7), and at 1 month (P<0.01,Table 7), 3 months (P<0.05,Table 7), and 6 months after surgery (P<0.05,Table 7). The MVT and length of ICU stay were longer in group C than in group D, (P<0.05,Table 2). As for the causes of death in groups C and D, right heart failure was the highest in group C, which also indicated the advantages of artificial pulmonary valve in protecting the right ventricle.
Surgical D also has shortcomings. Since the artificial pulmonary valve made by Goretex membrane will not grow with age, the incidence of PTP will increase as they get older.
This study has several limitations. First, we failed to detect the real differences between groups due to insufficient sample size. Second, the follow-up period afte initial surgery was insufficient to reflect the trend of the observation indexes, which may have introduced a certain bias on the statistical analysis results. In the future, studeis with larger samples and longer follow-up period should be conducted for further analysis. Some patients with radical conditions did not receive timely surgery, and some patients who needed early reintervention fail to undergo timely surgery for various reasons, including large PTP or severe PR. It was related to the economic conditions and ideas of the guardians of the patients. Some parents could not afford medical treatment, and some parents believed that their children were in good living conditions and did not need reoperation. In addition, it is also associated with the conception of several surgeons that the older the child is, the higher the success rate of reoperation is.